help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Journal of Clinical Endocrinology & Metabolism, doi:10.1210/jc.2004-2485
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
90/5/2988    most recent
Author Manuscript (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Powell, B. L.
Right arrow Articles by McCarthy, M. I.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Powell, B. L.
Right arrow Articles by McCarthy, M. I.
Related Collections
Right arrow Diabetes and Insulin
Right arrow Female Endocrinology
The Journal of Clinical Endocrinology & Metabolism Vol. 90, No. 5 2988-2993
Copyright © 2005 by The Endocrine Society

Analysis of Multiple Data Sets Reveals No Association between the Insulin Gene Variable Number Tandem Repeat Element and Polycystic Ovary Syndrome or Related Traits

Brenda L. Powell, Lema Haddad, Amanda Bennett, Neda Gharani, Ulla Sovio, Christopher J. Groves, Karen Rush, Micaela J. Goh, Gerard S. Conway, Aimo Ruokonen, Hannu Martikainen, Anneli Pouta, Saara Taponen, Anna-Liisa Hartikainen, Stephanie Halford, Eleftheria Zeggini, Marjo-Riitta Järvelin, Steve Franks and Mark I. McCarthy

Wellcome Trust Centre for Human Genetics, Oxford OX3 7BN, and Oxford Centre for Diabetes, Endocrinology, and Metabolism (B.L.P., A.B., C.J.G., E.Z., M.I.M.), Churchill Hospital, Oxford OX3 7LJ, United Kingdom; Genomic Medicine Faculty of Medicine, (L.H., N.G., S.H., M.I.M.), and Institute of Reproductive and Developmental Biology (S.F.), Imperial College (Hammersmith Campus), London W12 0NN, United Kingdom; Reproductive Endocrinology Group, Department of Obstetrics and Gynaecology (K.R., M.J.G., S.F.) and Departments of Epidemiology and Public Health (U.S., M-R.J.), Imperial College (St. Mary’s Campus), London W2 1PG, United Kingdom; Department of Endocrinology (G.S.C.), University College, London W1T 3AA, United Kingdom; Departments of Clinical Chemistry (A.R., S.T.), Obstetrics and Gynecology (S.T., H.M., A.P., A.-L.H.), and Public Health Science and General Practice (M.-R.J., S.T., A.P.), Oulu University Hospital and University of Oulu, Oulu FIN-90014, Finland

Address all correspondence and requests for reprints to: Professor Mark McCarthy, Robert Turner Professor of Diabetes, Oxford Centre for Diabetes, Endocrinology, and Metabolism, Churchill Hospital Site, Old Road, Headington, Oxford OX3 7LJ, United Kingdom. E-mail: mark.mccarthy{at}drl.ox.ac.uk.

Context: Variation at the insulin gene VNTR (variable number tandem repeat) minisatellite has been reported to be associated with polycystic ovary syndrome (PCOS), but findings have been inconsistent and all studies have featured small sample sizes.

Objective: To gain a robust understanding of the role of the INS-VNTR in PCOS susceptibility.

Design: Case-control, family-based association and quantitative trait analyses.

Setting and Participants: A UK population comprising 255 parent-offspring trios, 185 additional cases, and 1062 control subjects (cases and controls all British/Irish) as well as 1599 women from a northern Finland population-based birth cohort characterized for PCO symptomatology and testosterone levels. VNTR class was inferred from genotyping of the –23HphI variant.

Intervention(s): None.

Main Outcome Measure(s): INS-VNTR genotype frequencies between subject groups, body mass index, and testosterone levels by genotype.

Results: Case-control analyses in both UK and Finnish samples failed to confirm previously reported class III allele associations with PCOS (UK, P = 0.43, Finnish, P = 0.31; Kruskal-Wallis {chi}2). Transmission analysis in trios showed no excess transmission of either allele (P = 0.62), regardless of parent of origin (maternal: P = 0.73; paternal: P = 0.66). No association between genotype and testosterone levels was seen in any sample (UK PCOS subjects, P = 0.95; Finnish symptomatic cases, P = 0.38; Finnish control women, P = 0.58).

Conclusions: Despite the strong biological candidacy and supportive data from previous studies, we conclude that variation at the INS-VNTR has no major role in the development of PCOS.




This article has been cited by other articles:


Home page
Hum Reprod UpdateHome page
M. Simoni, C.B. Tempfer, B. Destenaves, and B.C.J.M. Fauser
Functional genetic polymorphisms and female reproductive disorders: Part I: polycystic ovary syndrome and ovarian response
Hum. Reprod. Update, September 1, 2008; 14(5): 459 - 484.
[Abstract] [Full Text] [PDF]


Home page
Physiol. GenomicsHome page
S. Le Fur, C. Auffray, F. Letourneur, C. Cruaud, C. Le Stunff, and P. Bougneres
Heterogeneity of class I INS VNTR allele association with insulin secretion in obese children
Physiol Genomics, May 16, 2006; 25(3): 480 - 484.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
K. Qin, D. A. Ehrmann, N. Cox, S. Refetoff, and R. L. Rosenfield
Identification of a Functional Polymorphism of the Human Type 5 17{beta}-Hydroxysteroid Dehydrogenase Gene Associated with Polycystic Ovary Syndrome
J. Clin. Endocrinol. Metab., January 1, 2006; 91(1): 270 - 276.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2005 by The Endocrine Society